Martingale Asset Management’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,072
Closed -$716K 831
2024
Q1
$716K Buy
18,072
+310
+2% +$12.3K 0.01% 543
2023
Q4
$703K Sell
17,762
-70
-0.4% -$2.93K 0.01% 529
2023
Q3
$791K Hold
17,832
0.02% 505
2023
Q2
$776K Buy
17,832
+1,501
+9% +$66K 0.02% 518
2023
Q1
$711K Buy
16,331
+5,221
+47% +$231K 0.01% 531
2022
Q4
$414K Buy
11,110
+1,005
+10% +$38.9K 0.01% 657
2022
Q3
$403K Buy
10,105
+700
+7% +$25.9K 0.01% 661
2022
Q2
$361K Hold
9,405
0.01% 711
2022
Q1
$373K Buy
9,405
+400
+4% +$15.7K 0.01% 696
2021
Q4
$374K Hold
9,005
﹤0.01% 698
2021
Q3
$380K Buy
+9,005
New +$453K 0.01% 716
2020
Q4
Sell
-10,404
Closed -$513K 997
2020
Q3
$513K Sell
10,404
-14,100
-58% -$780K 0.01% 808
2020
Q2
$1.43M Hold
24,504
0.02% 637
2020
Q1
$1.12M Hold
24,504
0.01% 643
2019
Q4
$1.62M Hold
24,504
0.02% 651
2019
Q3
$1.42M Sell
24,504
-1,900
-7% -$118K 0.01% 680
2019
Q2
$1.52M Buy
+26,404
New +$1.22M 0.02% 662

Other funds holding NRC

Martingale Asset Management's NRC Position: Q2 2024 in Review

Martingale Asset Management sold out of NRC Health Common Stock (NRC) in Q2 2024, closing a stake of 18,072 shares — an estimated $716K sold.

Martingale Asset Management first reported a position in NRC in Q2 2019 and held it in 17 quarters. The position peaked at $1.62M in Q4 2019. 136 funds tracked by Wall St. Rank hold NRC as of Q2 2024.

  • Martingale Asset Management reported no remaining NRC Health Common Stock position as of Q2 2024 after selling out during the quarter.
  • Martingale Asset Management sold 18,072 NRC Health Common Stock shares in Q2 2024, an estimated $716K.
  • Martingale Asset Management first reported a position in NRC Health Common Stock in Q2 2019 and held it in 17 quarters.
  • Martingale Asset Management's NRC Health Common Stock position peaked at $1.62M in Q4 2019.
  • 136 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2024.

Based on Martingale Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.